IL22 and asthma: Although we were previously able to demonstrate enhanced expression of sputum IL‐22 protein and the IL‐22/Fezakinumab gene response signature in patients with severe asthma,24 the numbers in OAC clusters 2 and 4 did not generate significant differences in this study.